Casper: IPO investors should have learnt from Eve
Private investors thought mattress company Casper was a unicorn – a start-up worth more than $1bn. Public investors don’t even think it is a third of one. After listing at $14.50 at the start of February, the shares have fallen sharply and at the time of writing the company has a market capitalisation of $312m. Those who invested in the private fundraising round which valued the company at $1.1bn have lost out, big time.
They could have learnt from investors in the UK who backed Eve Sleep, which listed in May 2017 at 100p per share, enjoyed a 9-month rise to 127p per share, before crashing down to just over 1p. It turns out mattress retailers shouldn’t be valued as innovative tech companies on either side of the Atlantic.
Sign up and read the full article
Register to continue reading our content.
Already a member? Login
Previous article Next article
For access to the top news and insights from the investment worldREGISTER FREE
More on Booking Holdings
The excitement surrounding the reopening of certain parts of the economy tells us a lot about the state…
Since our initial assessment of the impact of the coronavirus on the 25 companies in our…
More on TripAdvisor
Private investors thought mattress company Casper was a unicorn – a start-up worth more than $1bn.…
Revolution from business’s old guard has been slow to catch on. For much of the last…